Email this article Obstetric and gynecological management in a patient with abnormal invasion of the placenta (placenta percreta)
- Authors: Ishchenko A.I.1, Gorbenko O.Y.1, Khokhlova I.D.1, Zuev V.M.1, Dzhibladze T.A.1, Baburin D.V.1
-
Affiliations:
- I.M. Sechenov First Moscow State Medical University
- Issue: Vol 11, No 3 (2024)
- Pages: 350-359
- Section: Clinical case reports
- URL: https://ogarev-online.ru/2313-8726/article/view/268236
- DOI: https://doi.org/10.17816/aog626389
- ID: 268236
Cite item
Open Access
Access granted
Subscription Access
Abstract
Pathological placental invasion is a dangerous anomaly during pregnancy, which causes increased maternal morbidity and mortality. Patients with abnormal placental invasion may experience life-threatening uterine bleeding during delivery, particularly in cases of placenta percreta. This often requires surgical intervention, specifically a hysterectomy, which some researchers refer to as the “gold standard” treatment for pathological placental invasion, with rates ranging from 47% to 77.8%. Conversely, other researchers recommend a conservative approach, involving the complete removal of the placenta percreta, excision of damaged areas on the uterine walls and bladder, and metroplasty and restoration of the integrity of the.
This article presents a clinical case of a 40-year-old patient with a complicated obstetric history, including abnormal placental invasion (placenta percreta) involving the anterior wall of the uterus and the bladder.
Delayed diagnosis of such pathology leads to inappropriate treatment and, consequently, acute massive bleeding, posing a risk to the patient’s health and life. The applied comprehensive diagnostic and therapeutic measures facilitated the preservation of the pelvic organs and restoration of the patient’s reproductive function.
Keywords
Full Text
##article.viewOnOriginalSite##About the authors
Anatoliy I. Ishchenko
I.M. Sechenov First Moscow State Medical University
Email: 7205502@mail.ru
ORCID iD: 0000-0001-5733-953X
SPIN-code: 3294-3251
MD, Dr. Sci. (Medicine), Professor
Russian Federation, MoscowOksana Y. Gorbenko
I.M. Sechenov First Moscow State Medical University
Email: go2601@mail.ru
ORCID iD: 0000-0002-3435-4590
SPIN-code: 8725-1419
MD, Cand. Sci. (Medicine)
Russian Federation, MoscowIrina D. Khokhlova
I.M. Sechenov First Moscow State Medical University
Author for correspondence.
Email: irhohlova5@gmail.com
ORCID iD: 0000-0001-8547-6750
SPIN-code: 6858-5235
MD, Cand. Sci. (Medicine), Assistant Professor
Russian Federation, MoscowVladimir M. Zuev
I.M. Sechenov First Moscow State Medical University
Email: vlzuev@bk.ru
ORCID iD: 0000-0001-8715-2020
SPIN-code: 2857-0309
MD, Dr. Sci. (Medicine), Professor
Russian Federation, MoscowTea A. Dzhibladze
I.M. Sechenov First Moscow State Medical University
Email: djiba@bk.ru
ORCID iD: 0000-0003-1540-5628
SPIN-code: 5688-1084
MD, Dr. Sci. (Medicine), Professor
Russian Federation, MoscowDmitrii V. Baburin
I.M. Sechenov First Moscow State Medical University
Email: baburin_d_v@staff.sechenov.ru
ORCID iD: 0000-0003-2398-3348
SPIN-code: 3264-0730
Scopus Author ID: 57211347487
ResearcherId: AAQ-3984-2021
MD, Cand. Sci. (Medicine)
Russian Federation, MoscowReferences
- Ignatko IV, Davydov AI, Lebedev VA, et al. Placenta accreta spectrum: risk factors, terminology, classification, management strategies. Gynecology, Obstetrics and Perinatology. 2023;22(4):92–101. EDN: RFSBLS doi: 10.20953/1726-1678-2023-4-92-101
- Syundyukova EG, Chulanova YuS, Sashenkov SL, et al. Placenta previa and placenta accreta: questions of diagnosing and obstetric management. Russian Bulletin of Obstetrician-Gynecologist. 2022;22(3):12–20. EDN: STIDHQ doi: 10.17116/rosakush20222203112
- Jauniaux E, Ayres-de-Campos D, Langhoff-Roos J, et al.; FIGO Placenta Accreta Diagnosis and Management Expert Consensus Panel. FIGO classification for the clinical diagnosis of placenta accreta spectrum disorders. Int J Gynaecol Obstet. 2019;146(1):20–24. doi: 10.1002/ijgo.12761
- Jauniaux E, Jurkovic D, Hussein AM, Burton GJ. New insights into the etiopathology of placenta accreta spectrum. Am J Obstet Gynecol. 2022;227(3):384–391. doi: 10.1016/j.ajog.2022.02.038
- Baranovskaya EI. Etiology and diagnosis of placenta accreta. Russian Bulletin of Obstetrician-Gynecologist. 2020;20(3):24–28. EDN: CGFIOB doi: 10.17116/rosakush20202003124
- Wu S, Kocherginsky M, Hibbard JU. Abnormal placentation: twenty-year analysis. Am J Obstet Gynecol. 2005;192(5):1458–1461. doi: 10.1016/j.ajog.2004.12.074
- Pan XY, Wang YP, Zheng Z, et al. A marked increase in obstetric hysterectomy for placenta accreta. Chin Med J (Engl). 2015;128(16):2189–2193. doi: 10.4103/0366-6999.162508
- Matsuo K, Sangara RN, Matsuzaki S, et al. Placenta previa percreta with surrounding organ involvement: a proposal for management. Int J Gynecol Cancer. 2023;33(10):1633–1644. doi: 10.1136/ijgc-2023-004615
- Fonseca A, Ayres de Campos D. Maternal morbidity and mortality due to placenta accreta spectrum disorders. Best Pract Res Clin Obstet Gynaecol. 2021;72:84–91. doi: 10.1016/j.bpobgyn.2020.07.011
- Morlando M, Collins S. Placenta accreta spectrum disorders: challenges, risks, and management strategies. Int J Womens Health. 2020;12:1033–1045. doi: 10.2147/IJWH.S224191
- Shmakov RG, Pirogova MM, Vasilchenko ON, et al. Conservative surgery in abnormal placenta invasion (5-year experience of V.I. Kulakov National Medical Scientific Centre of Obstetrics, Gynaecology and Perinatal Medicine). Doctor.Ru. 2019;(11):29–34. EDN: UTPKCS doi: 10.31550/1727-2378-2019-166-11-29-34
- Davydov AI, Belotserkovtseva LD, Kilicheva II, Voloshchuk IN. Placenta accreta as a cause of postpartum haemorrhage: questions and answers. Gynecology, Obstetrics and Perinatology. 2014;13(3):52–62. EDN SLBTZZ
- Vinitsky AA, Shmakov RG, Chuprynin VD. Comparative assessment of the effectiveness of surgical hemostasis methods during organ-preserving delivery in patients with placenta accreta. Obstetrics and Gynecology. 2017;(7):68–74. EDN: ZCQQEV doi: 10.18565/aig.2017.7.68-74
- Tskhai VB, Pavlov AV, Garber YuG, et al. Evaluation of the effectiveness of uterine artery embolization in reducing intraoperative blood loss in pregnant women with complete placenta previa. Obstetrics and Gynecology. 2015;(8):59–64. EDN: ULQXVN
- Koyama E, Naruse K, Shigetomi H, et al. Combination of B-Lynch brace suture and uterine artery embolization for atonic bleeding after cesarean section in a patient with placenta previa accreta. J. Obstet. Gynaecol. Res. 2012;38(1):345–348. doi: 10.1111/j.1447-0756.2011.01699.x
- Jauniaux E, Bhide A. Prenatal ultrasound diagnosis and outcome of placenta previa accreta after cesarean delivery: a systematic review and meta-analysis. Am. J. Obstet. Gynecol. 2017;217(1):27–36. doi: 10.1016/j.ajog.2017.02.050
- Horgan R, Abuhamad A. Placenta accreta spectrum: prenatal diagnosis and management. Obstet Gynecol Clin North Am. 2022;49(3):423–438. doi: 10.1016/j.ogc.2022.02.004
- Kilcoyne A, Shenoy-Bhangle AS, Roberts DJ, et al. MRI of placenta accreta, placenta increta, and placenta percreta: pearls and pitfalls. Am. J. Roentgenol. 2017;208(1):214–221. doi: 10.2214/AJR.16.16281
- Einerson BD, Rodriguez CE, Kennedy AM, et al. Magnetic resonance imaging is often misleading when used as an adjunct to ultrasound in the management of placenta accreta spectrum disorders. Am. J. Obstet. Gynecol. 2018;218(6):618.e1–618.e7. doi: 10.1016/j.ajog.2018.03.013
- Dvoretskiy LI, Zaspa EA, Vokalyuk RM. Strategy and tactics of management of patients with iron deficiency anemia. RMJ. 2008;16(7):445–451. (In Russ.) EDN: THXCNF
- Matsuzaki S, Ueda Y, Matsuzaki S, et al. Relationship between abnormal placenta and obstetric outcomes: a meta-analysis. Biomedicines. 2023;11(6):1522. doi: 10.3390/biomedicines11061522
- Sentilhes L, Seco A, Azria E, et al. Conservative management or cesarean hysterectomy for placenta accreta spectrum: the PACCRETA prospective study. Am J Obstet Gynecol. 2022;226(6):839.e1–839.e24. doi: 10.1016/j.ajog.2021.12.013
Supplementary files
